Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Kun Xu, Ping Gao, Sheng Liu, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2265-2278.e14
Open Access | Times Cited: 113
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 81
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Zhenhao Fang, Lei Peng, Renata B. Filler, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 47
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera
Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Antiviral Research (2022) Vol. 204, pp. 105370-105370
Open Access | Times Cited: 42
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine
David W. Hawman, Kimberly Meade‐White, Chad S. Clancy, et al.
EBioMedicine (2022) Vol. 83, pp. 104196-104196
Open Access | Times Cited: 41
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
I‐Jung Lee, Cheng‐Pu Sun, Ping‐Yi Wu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 40
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
Daniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1750-1756
Open Access | Times Cited: 28
Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits
Martha M. O’Kennedy, Célia Abolnik, Tanja Smith, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2261-2269
Open Access | Times Cited: 17
Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
Qianqian Li, Mingjie Zhang, Ziteng Liang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 26
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
Michael S. Seaman, Mark J. Siedner, Julie Boucau, et al.
JCI Insight (2022) Vol. 7, Iss. 19
Open Access | Times Cited: 25
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S. Seaman, Mark J. Siedner, Julie Boucau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques
Catherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 14
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
Craig Collins, Dan L. Longo, William J. Murphy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
Krystallenia Paniskaki, Margarethe Konik, Moritz Anft, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis
Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8
SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
Qinhai Ma, Man Li, Lin Ma, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
Darin K. Edwards, Andrea Carfı́
Current Opinion in Immunology (2022) Vol. 77, pp. 102214-102214
Open Access | Times Cited: 13
mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern
Haomeng Wang, Zhao Chen, Zhenghua Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1550-1553
Open Access | Times Cited: 11
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
Farokh Dotiwala, Arun K. Upadhyay
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Zhenhao Fang, Lei Peng, Renata B. Filler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Responding to new challenges: is there a need to relook and revise our COVID-19 vaccination strategy?
Vipin M. Vashishtha, Puneet Kumar
Expert Review of Vaccines (2022) Vol. 21, Iss. 8, pp. 1015-1018
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top